New York A06709 amends cannabis law to mandate a course for practitioners certifying patients for medical cannabis and establishes an endocannabinoid.
New York A06709 amends the cannabis law to require practitioners to complete a course before certifying patients for medical cannabis. The course must cover pharmacology, contraindications, side effects, overdose prevention, drug interactions, dosing, routes of administration, risks, benefits, and impacts of cannabis consumption on body systems. The bill also establishes an endocannabinoid system awareness program within the office of cannabis awareness, in consultation with the department of health.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.